References
Barow E, Schneider SA, Bhatia KP, Ganos C. Oculogyric crises: etiology, pathophysiology and therapeutic approaches. Parkinsonism Relat Disord. 2017;36:3–9.
Shah A, Sobolewski B, Mittiga MR. Oculogyric Crisis. In: Knoop KJ, Stack LB, Storrow AB, Thurman RJ, editors. The Atlas of Emergency Medicine. 5th ed. New York: McGraw-Hill; 2021.
Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239–45.
Ritter MJ, Goodman BP, Sprung J, Wijdicks EFM. Ondansetron-induced multifocal encephalopathy. Mayo Clin Proc. 2003;78:1150–2.
Macachor JD, Kurniawan M, Loganathan SB. Ondansetron-induced oculogyric crisis. Eur J Anaesthesiol. 2014;31:712–3.
Ramakrishna H, Trentman TL, Hall BA, Sprung J. Ondansetron and carpopedal spasm. Can J Anaesth. 2008;55:55.
Lee CY, Ratnapalan S, Thompson M, Nathan PC, Closs J, French A, et al. Unusual reactions to 5-HT3 receptor antagonists in a child with rhabdomyosarcoma. J Popl Ther Clin Pharmacol. 2010;17:e1-4.
Patel A, Mittal S, Manchanda S, Puliyel JM. Ondansetron-induced dystonia, hypoglycemia, and seizures in a child. Ann Pharmacother. 2011;45:127–127.
Freedman SB, Hall M, Shah SS, Kharbanda AB, Aronson PL, Florin TA, et al. Impact of increasing ondansetron use on clinical outcomes in children with gastroenteritis. JAMA Pediatr. 2014;168:321–9.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
On behalf of all authors, the corresponding author states that there is no conflict of interest.
Rights and permissions
About this article
Cite this article
Cinar, E., Sanci, E., Utku, H.S. et al. Ondansetron-induced oculogyric crisis in a pediatric patient: case report. Can J Emerg Med 25, 534–536 (2023). https://doi.org/10.1007/s43678-023-00517-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s43678-023-00517-y